Page last updated: 2024-09-02

fingolimod hydrochloride and plx4032

fingolimod hydrochloride has been researched along with plx4032 in 2 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)
Trials
(fingolimod hydrochloride)
Recent Studies (post-2010)
(fingolimod hydrochloride)
Studies
(plx4032)
Trials
(plx4032)
Recent Studies (post-2010) (plx4032)
2,7711572,0621,6571031,587

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)plx4032 (IC50)
Chain A, AKAP9-BRAF fusion proteinHomo sapiens (human)0.031
RAF proto-oncogene serine/threonine-protein kinaseHomo sapiens (human)0.182
Serine/threonine-protein kinase A-RafHomo sapiens (human)0.521
Serine/threonine-protein kinase B-rafHomo sapiens (human)0.0897
Serine/threonine-protein kinase B-raf Mus musculus (house mouse)0.03
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.36
Dual specificity mitogen-activated protein kinase kinase 2Homo sapiens (human)1.5
Dual specificity mitogen-activated protein kinase kinase 1Homo sapiens (human)1.5
Mitogen-activated protein kinase kinase kinase 20Homo sapiens (human)0.0272

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leiner, P1
Abe, N; Banno, Y; Kanoh, H; Seishima, M; Takahashi, T1

Other Studies

2 other study(ies) available for fingolimod hydrochloride and plx4032

ArticleYear
[Galenus von Pergamon Prize 2012. Excellent research and innovation].
    MMW Fortschritte der Medizin, 2012, Nov-08, Volume: 154 Spec No 3

    Topics: Antineoplastic Agents; Awards and Prizes; Drug Approval; Drug Discovery; Drug Industry; Fingolimod Hydrochloride; Germany; Humans; Immunosuppressive Agents; Indoles; Organizational Innovation; Propylene Glycols; Sphingosine; Sulfonamides; Vemurafenib

2012
Synergistic effects of vemurafenib and fingolimod (FTY720) in vemurafenib‑resistant melanoma cell lines.
    Molecular medicine reports, 2018, Volume: 18, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Humans; Melanoma; Proto-Oncogene Proteins c-akt; Signal Transduction; Vemurafenib

2018
chemdatabank.com